These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

95 related articles for article (PubMed ID: 1454817)

  • 1. Human fusion proteins between interleukin 2 and IgM heavy chain are cytotoxic for cells expressing the interleukin 2 receptor.
    Vié H; Gauthier T; Breathnach R; Bonneville M; Godard A; Dietrich J; Karam G; Gesnel MC; Peyrat MA; Jacques Y; Soulillou JP
    Proc Natl Acad Sci U S A; 1992 Dec; 89(23):11337-41. PubMed ID: 1454817
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Rat interleukin-2 immunoglobulin M fusion proteins are cytotoxic in vitro for cells expressing the IL-2 receptor and can abolish cell-mediated immunity in vivo.
    Bogers WM; Lang F; Parker KE; Le Mauff B; Anegon I; Jacques Y; Soulillou JP
    Transplantation; 1994 Oct; 58(8):932-9. PubMed ID: 7940738
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Human interleukin-2-IgM heavy-chain-fusion proteins are cytotoxic for cells expressing the IL2 receptor.
    Vie H; Gauthier T; Breathnach R; Bonneville M; Godard A; Dietrich J; Karam G; Gesnel MC; Peyrat MA; Jacques Y
    Transplant Proc; 1993 Feb; 25(1 Pt 1):741-2. PubMed ID: 8438463
    [No Abstract]   [Full Text] [Related]  

  • 4. Chimeric interleukin 2 receptor alpha chain antibody derivatives with fused mu and gamma chains permit improved recruitment of effector functions.
    Schäffner M; François C; Kaluza B; Hock H; Jacques Y; Weidle UH
    Mol Immunol; 1995 Jan; 32(1):9-20. PubMed ID: 7870061
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Improving the efficacy of antibody-interleukin 2 fusion proteins by reducing their interaction with Fc receptors.
    Gillies SD; Lan Y; Lo KM; Super M; Wesolowski J
    Cancer Res; 1999 May; 59(9):2159-66. PubMed ID: 10232603
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Horse cytokine/IgG fusion proteins--mammalian expression of biologically active cytokines and a system to verify antibody specificity to equine cytokines.
    Wagner B; Robeson J; McCracken M; Wattrang E; Antczak DF
    Vet Immunol Immunopathol; 2005 May; 105(1-2):1-14. PubMed ID: 15797470
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Activation of complement by immunoglobulin M is impaired by the substitution serine-406----asparagine in the immunoglobulin mu heavy chain.
    Shulman MJ; Pennell N; Collins C; Hozumi N
    Proc Natl Acad Sci U S A; 1986 Oct; 83(20):7678-82. PubMed ID: 3094013
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Redirecting effector T cells through their IL-2 receptors.
    Lustgarten J; Marks J; Sherman LA
    J Immunol; 1999 Jan; 162(1):359-65. PubMed ID: 9886407
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cytoplasmic domains of the interleukin-2 receptor beta and gamma chains mediate the signal for T-cell proliferation.
    Nelson BH; Lord JD; Greenberg PD
    Nature; 1994 May; 369(6478):333-6. PubMed ID: 7514277
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A recombinant single chain antibody interleukin-2 fusion protein.
    Savage P; So A; Spooner RA; Epenetos AA
    Br J Cancer; 1993 Feb; 67(2):304-10. PubMed ID: 8431359
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Evolution of vertebrate IgM: complete amino acid sequence of the constant region of Ambystoma mexicanum mu chain deduced from cDNA sequence.
    Fellah JS; Wiles MV; Charlemagne J; Schwager J
    Eur J Immunol; 1992 Oct; 22(10):2595-601. PubMed ID: 1382992
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Antibody-targeted interleukin 2 stimulates T-cell killing of autologous tumor cells.
    Gillies SD; Reilly EB; Lo KM; Reisfeld RA
    Proc Natl Acad Sci U S A; 1992 Feb; 89(4):1428-32. PubMed ID: 1741398
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Targeting activated lymphocytes with an entirely human immunotoxin analogue: human pancreatic RNase1-human IL-2 fusion.
    Psarras K; Ueda M; Tanabe M; Kitajima M; Aiso S; Komatsu S; Seno M
    Cytokine; 2000 Jun; 12(6):786-90. PubMed ID: 10843765
    [TBL] [Abstract][Full Text] [Related]  

  • 14. IL-2 receptor-targeted cytolytic IL-2/Fc fusion protein treatment blocks diabetogenic autoimmunity in nonobese diabetic mice.
    Zheng XX; Steele AW; Hancock WW; Kawamoto K; Li XC; Nickerson PW; Li Y; Tian Y; Strom TB
    J Immunol; 1999 Oct; 163(7):4041-8. PubMed ID: 10491008
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The chimeric receptor between interleukin-2 receptor beta chain and interleukin-4 receptor transduces interleukin-2 signal.
    Izuhara K; Miyajima A; Harada N
    Biochem Biophys Res Commun; 1993 Feb; 190(3):992-1000. PubMed ID: 7679903
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Generation of switch hybrid DNA between Ig heavy chain-mu and downstream switch regions in B lymphocytes.
    Müller JR; Giese T; Henry DL; Mushinski JF; Marcu KB
    J Immunol; 1998 Aug; 161(3):1354-62. PubMed ID: 9686598
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Quantitation of immunoglobulin mu-gamma 1 heavy chain switch region recombination by a digestion-circularization polymerase chain reaction method.
    Chu CC; Paul WE; Max EE
    Proc Natl Acad Sci U S A; 1992 Aug; 89(15):6978-82. PubMed ID: 1495989
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Switch recombination in a transfected plasmid occurs preferentially in a B cell line that undergoes switch recombination of its chromosomal Ig heavy chain genes.
    Stavnezer J; Bradley SP; Rousseau N; Pearson T; Shanmugam A; Waite DJ; Rogers PR; Kenter AL
    J Immunol; 1999 Aug; 163(4):2028-40. PubMed ID: 10438941
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Lack of intermediate-affinity interleukin-2 receptor in mice leads to dependence on interleukin-2 receptor alpha, beta and gamma chain expression for T cell growth.
    Chastagner P; Moreau JL; Jacques Y; Tanaka T; Miyasaka M; Kondo M; Sugamura K; Thèze J
    Eur J Immunol; 1996 Jan; 26(1):201-6. PubMed ID: 8566067
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Binding activities and antitumor properties of a new mouse/human chimeric antibody specific for GD2 ganglioside antigen.
    Alvarez-Rueda N; Leprieur S; Clémenceau B; Supiot S; Sébille-Rivain V; Faivre-Chauvet A; Davodeau F; Paris F; Barbet J; Aubry J; Birklé S
    Clin Cancer Res; 2007 Sep; 13(18 Pt 2):5613s-5620s. PubMed ID: 17875797
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.